Transfusing Convalescent Plasma as Post-Exposure Prophylaxis Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Double-Blinded, Phase 2 Randomized, Controlled Trial.

Transfusing Convalescent Plasma as Post-Exposure Prophylaxis Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Double-Blinded, Phase 2 Randomized, Controlled Trial. Clin Infect Dis. 2023 02 08; 76(3):e477-e486.

View in: PubMed

subject areas

Adolescent
Adult
Double-Blind Method
Humans
Immunization, Passive
Post-Exposure Prophylaxis

authors with profiles

Giselle Mosnaim